Literature DB >> 20345750

Insulin-like growth factor binding protein-1 activates integrin-mediated intracellular signaling and migration in oligodendrocytes.

Daniel Chesik1, Jacques De Keyser, Reinier Bron, Gwenny M Fuhler.   

Abstract

In multiple sclerosis (MS), oligodendrocytes in lesions are lost, leaving damaged tissue virtually devoid of these myelin-producing cells. Our group has recently demonstrated enhanced expression of insulin-like growth factor (IGF) binding protein-1 (IGFBP-1) in oligodendrocytes (CNPase(+)) localized adjacent to MS lesions. In the present study, we demonstrate IGF-1-independent actions of IGFBP-1 on OLN-93 oligodendroglial cells, including activation of kinases ERK1/2, focal adhesion kinase and p21-activated kinase as well as small monomeric GTPases Rac and Ral. Activation of these intracellular signaling components was inhibited by GRGDS peptide, indicating signaling through integrin receptors. While both IGF-1 and IGFBP-1 demonstrated rapid induction of actin polymerization, IGFBP-1 proved to be a more potent inducer of migration than IGF-1, inducing a threefold increased migration rate. Furthermore, through integrin receptor signaling IGFBP-1 induced rapid transient translocalization of intracellular Rac toward punctuated structures followed by translocation of Rac to the plasma membrane. Our results suggest that up-regulation of IGFBP-1 in oligodendrocytes in MS may serve two functions: (i) regulate IGF-1 actions, (ii) exert IGF-independent effects through its RGD sequence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20345750     DOI: 10.1111/j.1471-4159.2010.06703.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Neurodevelopmental effects of insulin-like growth factor signaling.

Authors:  John O'Kusky; Ping Ye
Journal:  Front Neuroendocrinol       Date:  2012-06-16       Impact factor: 8.606

2.  Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma.

Authors:  Bin Dai; Bai Ruan; Juan Wu; Jianlin Wang; Runze Shang; Wei Sun; Xia Li; Kefeng Dou; Desheng Wang; Yu Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 3.  IGF-I/IGFBP system: metabolism outline and physical exercise.

Authors:  R Gatti; E F De Palo; G Antonelli; P Spinella
Journal:  J Endocrinol Invest       Date:  2012-06-18       Impact factor: 4.256

Review 4.  IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications.

Authors:  Yi-Wei Lin; Xue-Fen Weng; Bin-Liang Huang; Hai-Peng Guo; Yi-Wei Xu; Yu-Hui Peng
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

5.  Age-changes in gene expression in primary mixed glia cultures from young vs. old rat cerebral cortex are modified by interactions with neurons.

Authors:  Isaac Kremsky; Todd E Morgan; Xiaogang Hou; Lei Li; Caleb E Finch
Journal:  Brain Behav Immun       Date:  2011-12-28       Impact factor: 7.217

Review 6.  PXR: More Than Just a Master Xenobiotic Receptor.

Authors:  Peter O Oladimeji; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2017-11-07       Impact factor: 4.436

7.  Pregnane X Receptor Represses HNF4α Gene to Induce Insulin-Like Growth Factor-Binding Protein IGFBP1 that Alters Morphology of and Migrates HepG2 Cells.

Authors:  Susumu Kodama; Yuichi Yamazaki; Masahiko Negishi
Journal:  Mol Pharmacol       Date:  2015-07-31       Impact factor: 4.436

8.  Insulinlike Growth Factor-Binding Protein-1 Improves Vascular Endothelial Repair in Male Mice in the Setting of Insulin Resistance.

Authors:  Amir Aziz; Natalie J Haywood; Paul A Cordell; Jess Smith; Nadira Y Yuldasheva; Anshuman Sengupta; Noman Ali; Ben N Mercer; Romana S Mughal; Kirsten Riches; Richard M Cubbon; Karen E Porter; Mark T Kearney; Stephen B Wheatcroft
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

9.  Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis.

Authors:  Adil Rajwani; Vivienne Ezzat; Jessica Smith; Nadira Y Yuldasheva; Edward R Duncan; Matthew Gage; Richard M Cubbon; Matthew B Kahn; Helen Imrie; Afroze Abbas; Hema Viswambharan; Amir Aziz; Piruthivi Sukumar; Antonio Vidal-Puig; Jaswinder K Sethi; Shouhong Xuan; Ajay M Shah; Peter J Grant; Karen E Porter; Mark T Kearney; Stephen B Wheatcroft
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

10.  Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines.

Authors:  Danielle Seurin; Alain Lombet; Sylvie Babajko; François Godeau; Jean-Marc Ricort
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.